Author

Sierra Reed

Institution: Access to Advanced Health Institute

Observed institutions: Infectious Disease Research Institute, Access to Advanced Health Institute

ORCID: 0000-0002-7470-9595

Observed ORCID: 0000-0002-7470-9595

OpenAlex ID: A5030474614

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

2022 · Emily A. Voigt, Alana Gerhardt, et al. · npj Vaccines · 93

A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery

2022 · Alana Gerhardt, Emily Voigt, et al. · Molecular Therapy — Methods & Clinical Development · 87

Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission

2025 · Madeleine F. Jennewein, Michael D. Schultz, et al. · Molecular Therapy · 24

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy

2021 · Mayuresh M. Abhyankar, Mark T. Orr, et al. · Frontiers in Immunology · 24

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies

2022 · Adrian Rice, Mohit Verma, et al. · Frontiers in Immunology · 16

Intranasal replicon vaccine establishes mucosal immunity and protects against H5N1 and H7N9 influenza

2026 · Matthew R. Ykema, Michael A. Davis, et al. · Nature Communications · 14

A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses

2025 · Peter Battisti, Matthew R. Ykema, et al. · Frontiers in Immunology · 9

Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

2022 · Emily A. Voigt, Alana Gerhardt, et al. · npj Vaccines · 6

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization

2024 · William R. Lykins, Jeroen Pollet, et al. · Frontiers in Immunology · 3

Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine

2024 · William R. Lykins, Jeroen Pollet, et al. · Frontiers in Drug Delivery · 2

Self-amplifying RNA-based activation of HIV-1 broadly neutralizing antibody B cell precursors 2690

2025 · Parul Agrawal, Madison M. Means, et al. · The Journal of Immunology

Works count: 11

Citation count: 278

H-index: 7

I10-index: 6